Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 1/20 | 0.55 |
| ▸ | FYN | P06241 | 1/20 | 0.55 |
| ▸ | ING2 | Q9H160 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | NT5E | P21589 | 3/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | CASP6 | P55212 | 3/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | NSD2 | O96028 | 3/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.40 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.39 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL124133 | 1.00 | LCK (0.55) | LCKFYNING2TSHRSMN1; SMN2 | |
| SCHEMBL219222 | 0.96 | LCK (0.57) | LCKFYNING2TSHRSMN1; SMN2 | |
| SCHEMBL216136 | 0.93 | LCK (0.55) | LCKFYNING2TSHRSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL9775388 | 0.93 | LCK (0.55) | LCKFYNING2TSHRSMN1; SMN2 | |
| SCHEMBL9220939 | 0.93 | LCK (0.55) | LCKFYNING2TSHRSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL23302213 | 0.93 | LCK (0.55) | LCKFYNING2TSHRSMN1; SMN2 | |
| SCHEMBL26691692 | 0.88 | LMNA (0.52) | LCKFYNING2TSHRSMN1; SMN2 | |
| SCHEMBL27752734 | 0.88 | LMNA (0.52) | LCKFYNING2TSHRSMN1; SMN2 | |
| SCHEMBL10893545 | 0.86 | ALDH1A1 (0.58) | LCKFYNING2TSHRSMN1; SMN2 | |
| SCHEMBL7803304 | 0.84 | LCK (0.48) | LCKFYNING2TSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2009723-A1 | COMPOSITE ELECTROLYTE MEMBRANE COMPRISING IMIDE NETWORK POLYMER CROSSLINKED WITH STRONGLY ACIDIC GROUP, METHOD FOR MANUFACTURING THE COMPOSITE ELECTROLYTE MEMBRANE, AND FUEL CELL | Toyota Jidosha Kabushiki Kaisha (JP) | 2008-12-31 | — | — | EP | disclosed |
| US-20040010028-A1 | Self-assembled nanostructures with macroscopic polar order | TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE | 2004-01-15 | — | — | US | disclosed |
| WO-2002044124-A9 | SELF-ASSEMBLED NANOSTRUCTURES WITH MACROSCOPIC POLAR ORDER | UNIV COLUMBIA (US) | 2003-11-13 | — | — | WO | disclosed |
| WO-2002044124-A2 | SELF-ASSEMBLED NANOSTRUCTURES WITH MACROSCOPIC POLAR ORDER | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2002-06-06 | — | — | WO | disclosed |
| US-5378550-A | Electrolytes for power sources | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) | 1995-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040010028-A1 | Self-assembled nanostructures with macroscopic polar order | PIEZO1, PYM1, KCNH1 | LCK 882/4885FYN 1026/4885ING2 3627/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.